A universal MHCII technology platform to characterize antigen-specific CD4⁺ T cells

Area of Science:

• Immunology
• Cell Biology

Background:

• CD4+ T cells are vital for immune function, but existing methods struggle to preserve their ex vivo phenotype, limiting in vivo function insights.
• Understanding CD4+ T cell characteristics is crucial for both health and disease research.

Purpose of the Study:

• To develop a flexible, rapid, and robust platform for ex vivo CD4+ T cell identification, immunophenotyping, and sorting.
• To enable high-throughput, personalized CD4+ T cell analysis.

Main Methods:

• Combines MHCII allele purification, allele-independent peptide loading, and multiplexed flow cytometry.
• Utilizes single-cell sorting and multimodal analyses.

Main Results:

• Successfully identified and characterized antigen-specific CD4+ T cells relevant to COVID-19 and cancer neoantigen immunotherapy.
• Demonstrated a platform for high-throughput personalized CD4+ T cell identification and immunophenotyping.

Conclusions:

• The developed platform offers a significant advancement for detecting and characterizing CD4+ T cells across various diseases.
• This technology has the potential to guide CD4+ T cell epitope design for future immunization strategies.